Imatge de la portada

Cancer Immunology

The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributio...

Descripció completa

Guardat en:
Format: Online
Idioma:anglès
Publicat: MDPI - Multidisciplinary Digital Publishing Institute 2022
Matèries:
NKG2D
CAR T
IL-7
prostate cancer
cell therapy
CD19-CAR-T
B cell aplasia
KIR
PD-1
inhibitory CAR
tumor-infiltrating lymphocytes
tumor microenvironment
immunotherapy
NK cells
cancer stem cells (CSCs)
antibody-dependent cellular cytotoxicity (ADCC)
differentiation
cytotoxicity
IFN-γ
osteoclasts
MICA/B mAb
DNA methylation
RNA methylation
S-adenosylmethionine (SAM)
cancer
innate immunity
adaptive immunity
T cells
m6A
PD-L1
resistance
immune checkpoints
cancer vaccine
combination immunotherapy
TCR diversity
organ transplantation
carcinoma
epidemiologic studies
immunosuppression
CTLA-4
Treg cells
immune checkpoint inhibitors
CD28
antigen-presenting cells
IL15
colon cancer
melanoma
uveal
BAP1
anti-PD-1
anti-CTLA-4
TIL
classical and endemic Kaposi Sarcoma
systemic treatment
multi-state modelling
treatment free interval
chemotherapy
interferon
triple negative breast cancer
immunomodulation
bispecific antibody
sortase A
chemo-enzymatic approach
anti-CD20 antibody
Fab
BiFab
colorectal cancer
dendritic cells
Atypical Chemokine Receptor 4 (ACKR4)
T-cell priming
immune checkpoint blockade
primary liver cancer
kynurenine pathway
immune evasion
indoleamine 2,3 dioxygenase 1
tryptophan 2,3 dioxygenase 2
IDO inhibitor
antigen presenting cells
n/a
thema EDItEUR::M Medicine and Nursing
Accés en línia:ONIX_20220111_9783036525730_940
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
Sumari:The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue.

Ítems similars